24945-13-9

Basic information

• Product Name: 2,2-DIMETHYL-TETRAHYDRO-PYRAN-4-OL
• Synonyms: 2,2-DIMETHYL-TETRAHYDRO-PYRAN-4-OL;2,2-Dimethyltetrahydro-2H-pyran-4-ol
• CAS NO: 24945-13-9
• Molecular Formula: C₇H₁₄O₂
• Molecular Weight: 130.18
• Mol File: 24945-13-9.mol

Chemical Properties

• Boiling Point: 205.4°C at 760 mmHg
• Flash Point: 80.9°C
• Appearance: /
• Density: 0.979g/cm³
• Vapor Pressure: 0.0595mmHg at 25°C
• Refractive Index: 1.447
• Storage Temp.: 2-8°C
• CAS DataBase Reference: 2,2-DIMETHYL-TETRAHYDRO-PYRAN-4-OL(CAS DataBase Reference)
• NIST Chemistry Reference: 2,2-DIMETHYL-TETRAHYDRO-PYRAN-4-OL(24945-13-9)
• EPA Substance Registry System: 2,2-DIMETHYL-TETRAHYDRO-PYRAN-4-OL(24945-13-9)

Safety Data

• Hazardous Substances Data: 24945-13-9(Hazardous Substances Data)

Usage

Uses

Used in Food and Beverage Industry:
2,2-DIMETHYL-TETRAHYDRO-PYRAN-4-OL is used as a flavor and fragrance ingredient for enhancing the sensory experience of food and beverages, contributing to their overall appeal and consumer satisfaction.
Used in Perfumery:
In the perfume industry, 2,2-DIMETHYL-TETRAHYDRO-PYRAN-4-OL is utilized as a component in creating various scents, adding depth and complexity to perfume compositions.
Used in Detergents and Personal Care Products:
2,2-DIMETHYL-TETRAHYDRO-PYRAN-4-OL is employed in the formulation of detergents and personal care products to provide a pleasant scent and improve the overall user experience.
Used in Medicinal Research:
2,2-DIMETHYL-TETRAHYDRO-PYRAN-4-OL is studied for its potential medicinal properties, such as anti-inflammatory and antioxidant effects, indicating its possible use in the development of pharmaceuticals and health supplements.

InChI:InChI=1/C7H14O2/c1-7(2)5-6(8)3-4-9-7/h6,8H,3-5H2,1-2H3

Upstream product

• 627-27-0 homoalylic alcohol 
• 67-64-1 acetone 
• 1194-16-7 2,2-dimethyltetrahydropyran-4-one 
• 67-56-1 methanol 
• 109752-89-8 4-hydroxymethyl-2,2-dimethyltetrahydropyran-4-ol 
• 7664-93-9 sulfuric acid 

Downstream Products

• 1307304-82-0 C₁₄H₂₀O₄S 
• 1307304-83-1 C₁₄H₂₀O₄S 
• 1028719-07-4 3-{4-[(2,2-dimethyltetrahydro-2H-pyran-4-yl)oxy]phenyl}-2-ethyl-5-{[2'-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]methyl}-6-propylpyrimidin-4(3H)-one 

Relevant articles and documents

HORMONE RECEPTOR MODULATORS FOR TREATING METABOLIC MUTAGENIC AND FIBROTIC CONDITIONS AND DISORDERS

The invention relates to activators of FXR useful in the treatment of autoimmune disorders, liver disease, intestinal disease, kidney disease, cancer, and other diseases in which FXR plays a role, having the Formula (I): wherein L1, A, X1

HORMONE RECEPTOR MODULATORS FOR TREATING METABOLIC CONDITIONS AND DISORDERS

The invention relates to activators of FXR useful in the treatment of autoimmune disorders, liver disease, intestinal disease, kidney disease, cancer, and other diseases in which FXR plays a role, having the Formula (I): (I), wherein L1, A, X1, X2, R1, R2, and R3 are described herein.

HEPATITIS C VIRUS INHIBITORS

The present disclosure relates to compounds, compositions and methods for the treatment of hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment o